Abstract Background The widespread incorporation of next-generation sequencing into clinical oncology has yielded an unprecedented amount of molecular data from thousands of patients. A main current challenge is to find out reliable ways to extrapolate results from one group of patients to another and to bring rationale to individual cases in the light of what is known from the cohorts. Results We present OncoGenomic Landscapes, a framework to analyze and display thousands of cancer genomic profiles in a 2D space. Our tool allows users to rapidly assess the heterogeneity of large cohorts, enabling the comparison to other groups of patients, and using driver genes as landmarks to aid in the interpretation of the landscapes. In our web-server...
Cancer is among the leading causes of mortality worldwide and the number of cancer-related deaths is...
Cancer is a heterogeneous disease, which is comprised of a collection of diseases traditionally cate...
The use of genome-wide data in cancer research, for the identification of groups of patients with si...
Although large-scale efforts for molecular profiling of cancer samples provide multiple data types f...
Cancer is a complex disease caused by somatic alterations of the genome and epigenome in tumor cells...
BACKGROUND: Precision medicine in oncology relies on rapid associations between patient-specific var...
In cancer research, genomic profiles are often extracted from homogenized macrodissections of tissue...
SummarySystematic studies of cancer genomes have provided unprecedented insights into the molecular ...
Cancer genomics refers to the study of the genome and transcriptome from tumour cells and their norm...
Summary Systematic studies of cancer genomes have provided unprecedented insights into the molecular...
Recent advances in high-throughput genomic technologies and high-performance computing have propelle...
The complexity of human cancer underlies its devastating clinical consequences. Drugs designed to ta...
Ongoing cancer genome characterization studies continue to elucidate the spectrum of genomic abnorma...
Systematic studies of cancer genomes have provided unprecedented insights into the molecular nature ...
none3The recent improvement of the high-throughput sequencing technologies is having a strong impact...
Cancer is among the leading causes of mortality worldwide and the number of cancer-related deaths is...
Cancer is a heterogeneous disease, which is comprised of a collection of diseases traditionally cate...
The use of genome-wide data in cancer research, for the identification of groups of patients with si...
Although large-scale efforts for molecular profiling of cancer samples provide multiple data types f...
Cancer is a complex disease caused by somatic alterations of the genome and epigenome in tumor cells...
BACKGROUND: Precision medicine in oncology relies on rapid associations between patient-specific var...
In cancer research, genomic profiles are often extracted from homogenized macrodissections of tissue...
SummarySystematic studies of cancer genomes have provided unprecedented insights into the molecular ...
Cancer genomics refers to the study of the genome and transcriptome from tumour cells and their norm...
Summary Systematic studies of cancer genomes have provided unprecedented insights into the molecular...
Recent advances in high-throughput genomic technologies and high-performance computing have propelle...
The complexity of human cancer underlies its devastating clinical consequences. Drugs designed to ta...
Ongoing cancer genome characterization studies continue to elucidate the spectrum of genomic abnorma...
Systematic studies of cancer genomes have provided unprecedented insights into the molecular nature ...
none3The recent improvement of the high-throughput sequencing technologies is having a strong impact...
Cancer is among the leading causes of mortality worldwide and the number of cancer-related deaths is...
Cancer is a heterogeneous disease, which is comprised of a collection of diseases traditionally cate...
The use of genome-wide data in cancer research, for the identification of groups of patients with si...